Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Arista
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : Virtua Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 30, 2022
Lead Product(s) : Arista
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : Virtua Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : PF-06480605
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Antimicrobial Effectiveness of CHG/IPA
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 29, 2019
Lead Product(s) : PF-06480605
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Octenidine Hydrochloride
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 26, 2017
Lead Product(s) : Octenidine Hydrochloride
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Octenidine Hydrochloride
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 21, 2017
Lead Product(s) : Octenidine Hydrochloride
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable